AKT1 and polycystic ovary syndrome: Silencing of lncRNA maternally expressed gene 3 (MEG3) attenuated sex hormone dysregulation and ovarian histopathological changes in rats with PCOS and promoted follicle cell development and maturation by targeting the miR-21-3p/PI3K/AKT/mTOR pathway.